Home 2020

Archives

microvascular dysfunction, treatment

LRG1: An emerging therapeutic target for the treatment of microvascular dysfunction

John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.
vessel growth

Vessel growth in health and disease

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.

Follow Us

Advertisements